Healthcare Economist December 11, 2023
That is the question asked by a recent paper by Nikpay et al. (2023). The authors begin by describing the magnitude of the 340B program:
The 340B drug discount program is designed to lower drug costs and increase drug profits for safety-net providers, called “covered entities,” by entitling them to discounts on drugs for all patients, including those with insurance. The size of these discounts is approximately 50% off Medicare’s reimbursement for many drugs.1 Profits generated from billing insurers for discounted drugs, recently valued at almost $50 billion,..today, 2750 hospitals are enrolled in the program
Not only can a hospital’s in-house pharmacy participate in 340B, but so can contracted outpatient pharmacy. There are over 73,000 contract pharmacies that...
Today's Sponsors
Today's Sponsor